Call 1-888-4ASSIST (1-888-427-7478) to speak to a Nurse Ambassador, Monday–Friday 9 AM–8 PM ET.
Amgen Nurse Ambassadors are a single point of contact who take the time to help you and your caregiver identify which types of assistance are most important to you. They will assist you in finding resources, so that you and your caregiver can focus on your treatment. They do not, however, provide medical advice or case management services.*
Whatever insurance you have—even if you have none—the Nurse Ambassador can help you understand how your Amgen medicine may be covered and refer you to programs that may be able to help you afford it, such as Amgen FIRST STEP™ or other independent nonprofit organizations.†
Sometimes you need someone who knows what you’re going through. The Nurse Ambassador can refer you to independent nonprofit organizations† that may provide you with community resources, one-on-one counseling services, and local support groups.
If you need assistance with travel that’s connected to your therapy, the Nurse Ambassador can put you in touch with independent nonprofit organizations that may provide you help with gas, tolls, parking, airfare, and lodging.
If you have any questions about your Amgen medicine, the Nurse Ambassador may help you find the answers.
*Patients should always talk to their health care provider about any medical decisions or concerns they may have.
†Provided through independent nonprofit patient assistance programs; program eligibility is based on the nonprofit’s criteria. Amgen has no control over these programs and provides referrals as a courtesy only.
Are you familiar with these groups and organizations? They offer valuable resources and support that may be right for you or your loved one.
What is the most important information I should know about BLINCYTO®?
Who should not receive BLINCYTO®?
What should I avoid while receiving BLINCYTO®?
Before receiving BLINCYTO®, tell your health care provider about all of your medical conditions, including if you or your child:
BLINCYTO® (blinatumomab) is a prescription medicine used to treat B-cell precursor acute lymphoblastic leukemia (ALL) in patients who still have detectable traces of cancer after chemotherapy.
The approval of BLINCYTO® in these patients is based on a study that measured response rate and duration of response. There are ongoing studies to confirm clinical benefit.